Teriparatide Subcutaneous Injection

Teriparatide Subcutaneous Injection
Product Description

Teriparatide Subcutaneous Injection (historically labeled as 600 mcg / 2.4 mL, delivering a target concentration of 250 mcg/mL) is a high-potency recombinant human parathyroid hormone (rhPTH 1-34). Classified as an anabolic (bone-forming) agent, it actively stimulates osteoblast activity to rebuild bone architecture and lower the risk of osteoporotic fractures.

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Therapeutic Class: Parathyroid hormone analogue; bone formation stimulant.Primary Clinical Indications: Postmenopausal Osteoporosis: Prescribed for women with postmenopausal osteoporosis who exhibit a high risk for bone fractures or have failed prior bisphosphonate therapies. Primary/Hypogonadal Osteoporosis in Men: Indicated to increase bone mineral density (BMD) in men suffering from severe bone loss. Glucocorticoid-Induced Osteoporosis: Deployed to treat systemic bone loss secondary to sustained, long-term therapeutic use of corticosteroid medications (e.g., prednisone).

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swiftmed International Private Limited (78)

  • Rifampicin + Isoniazid

    Product Rifampicin + Isoniazid

    Rifampicin + Isoniazid Tablets 150 mg/150 mg are a fixed-dose combination (FDC) antitubercular medicine containing two first-line anti-tuberculosis agents: Rifampicin 150 mg and Isoniazid 150 mg. The combination is formulated to provide effective bactericidal activity against Mycobacterium tuberculosis whi...
  • Rifaximin

    Product Rifaximin

    Rifaximin 100 mg/5 ml Oral Suspension is a non-systemic, gastrointestinal-targeted antibiotic formulated to treat bacterial infections of the digestive tract. Unlike conventional antibiotics that enter the bloodstream, this oral liquid acts locally inside the intestines. It provides targeted therapy agains...
  • Rivaroxaban

    Product Rivaroxaban

    Rivaroxaban Oral Tablets are high-potency, direct-acting oral anticoagulants (DOACs) prescribed to prevent and treat serious blood-clotting disorders. As a highly selective inhibitor of clotting Factor Xa, this medication helps maintain smooth blood flow without requiring the constant blood monitoring rout...
  • Semaglutide for Injection

    Product Semaglutide for Injection

    Semaglutide for Injection (Prefill Syringe, Single Dose Pen, Multi Dose Pen) available in 0.25mg/0.5mg/1mg/1.7mg/2.4mg strengths. Available with CTD dossier modules 1 to 4 and clinical trial underway. Product is available from a WHO GMP certified plant and available for registration and direct supply to te...
  • Sofosbuvir

    Product Sofosbuvir

    Sofosbuvir 400 mg Tablets are high-potency, direct-acting antiviral (DAA) oral medications prescribed to treat chronic Hepatitis C Virus (HCV) infections. As a foundational nucleotide analog polymerase inhibitor, it blocks viral replication across multiple genotypes of the virus, typically yielding high cu...
  • Tegoprazan tablets

    Product Tegoprazan tablets

    Tegoprazan oral tablets are a potent, next-generation gastrointestinal medication prescribed to manage acid-related disorders. Classified as a potassium-competitive acid blocker (P-CAB), tegoprazan provides a faster, more stable, and food-independent reduction in stomach acid compared to traditional proton...
  • Thalidomide

    Product Thalidomide

    Thalidomide oral capsules (available in 50 mg, 100 mg, and 200 mg strengths) are high-potency immunomodulatory, anti-inflammatory, and anti-angiogenic agents. Once restricted due to its history of severe birth defects, thalidomide is highly regulated and prescribed to manage specific cancers and complex de...
  • Tiotropium+ Formoterol + Ciclesonide

    Product Tiotropium+ Formoterol + Ciclesonide

    Tiotropium (9 mcg), Formoterol (6 mcg), and Ciclesonide (200 mcg) Inhalation Aerosol is a high-potency, fixed-dose triple combination therapy. It is prescribed for the long-term maintenance management of severe Chronic Obstructive Pulmonary Disease (COPD) and refractory asthma. This configuration merges th...
  • Vasopressin Injection

    Product Vasopressin Injection

    Vasopressin Injection is a highly potent, sterile intravenous or intra-arterial medication prescribed to stabilize hemodynamics in critical care emergencies and manage severe fluid retention imbalances. Historically known as antidiuretic hormone (ADH), this synthetic formulation acts directly on vascular s...
  • Vonoprazan Tablets

    Product Vonoprazan Tablets

    We provide Vonoprazan Tablets 10mg & 20mg for global B2B pharmaceutical partnerships, including contract manufacturing, licensing opportunities, and finished dosage supply solutions 
    Active Ingredient: Vonoprazan Fumarate Strengths Available: 10mg & 20mg tabletsTherapeutic Class: P...
  • Budesonide

    Product Budesonide

    Budesonide Inhalation and Intranasal Formulations are highly effective, locally acting corticosteroid medications prescribed in various microgram strengths to suppress chronic inflammation in the respiratory and nasal passages. By acting directly on target tissues, budesonide reduces mucosal swelling, mucu...
  • Buprenorphine + Naloxone Sublingual

    Product Buprenorphine + Naloxone Sublingual

    Buprenorphine and Naloxone Sublingual Tablets (2 mg / 0.5 mg strength) are high-potency, federally controlled prescription medications formulated for the maintenance treatment of Opioid Use Disorder (OUD). This combination utilizes a unique dual-component mechanism—pairing a partial opioid agonist with an ...